GSK-376501

DB12654InvestigationalSmall molecule

GSK376501 has been used in trials studying the treatment and diagnostic of Type 2 Diabetes Mellitus.

Chemical structure of GSK-376501
Formula / weight
C32H37NO6 · 531.649 g/mol (avg)
Code names
GSK376501 · GSK-376501A

Resolves to

Compound
UNII7511RY999UCAS1010412-80-2PubChem24946920
Structure
InChIKeyOIDYMQICWGYEDR-UHFFFAOYSA-NSMILESCOCCOC1=CC(OCCOC)=CC(CN2C3=CC=CC=C3C(=C2C(O)=O)C2=CC=C(C=C2)C(C)(C)C)=C1

What you can answer from here — as of June 12, 2020

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of GSK-376501, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In